Document is current
Any future updates will be listed below
-
Authors
Brudno, Jennifer N. https://orcid.org/0000-0002-7904-8415
Kochenderfer, James N. https://orcid.org/0000-0002-4362-9875
- License Information
-
More Information
Article History
Accepted: 29 April 2024
First Online: 20 May 2024
Competing interests
: J.N.B. serves on the scientific advisory board of Kyverna Therapeutics (unpaid position). J.N.K. receives royalties from Kite Pharma (a Gilead company), Celgene/Bristol Myers Squibb and Kyverna Therapeutics; and research funding from Kite (a Gilead company) and Celgene/Bristol Myers Squibb.
